Captor Therapeutics Spolka Akcyjna (WSE: CTX)
Poland flag Poland · Delayed Price · Currency is PLN
57.40
+6.40 (12.55%)
Nov 20, 2024, 2:17 PM CET

CTX Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
19.3613.29.163.99-
Revenue Growth (YoY)
54.39%44.15%129.75%--
Cost of Revenue
8.326.32.090.74-
Gross Profit
11.046.97.073.25-
Selling, General & Admin
17.3422.1824.0730.689.89
Research & Development
44.1164.8544.1623.1223.57
Other Operating Expenses
-8.67-7.11-22.79-17.71-21.24
Operating Expenses
52.7979.9245.4436.0912.22
Operating Income
-41.75-73.02-38.36-32.84-12.22
Interest Expense
-0.34-0.27-0.32-0.4-0.39
Interest & Investment Income
1.333.083.13--
Currency Exchange Gain (Loss)
-0.35-0.27-0.08-0.06-0.09
Other Non Operating Income (Expenses)
-0.05-0.05-0.26-0.41-
EBT Excluding Unusual Items
-41.15-70.53-35.89-33.7-12.69
Asset Writedown
---1.13-
Pretax Income
-41.15-70.53-35.89-32.57-12.69
Income Tax Expense
-0.06---
Net Income
-41.15-70.58-35.89-32.57-12.69
Net Income to Common
-41.15-70.58-35.89-32.57-12.69
Shares Outstanding (Basic)
55444
Shares Outstanding (Diluted)
55444
Shares Change (YoY)
18.85%11.46%0.97%14.99%-
EPS (Basic)
-8.25-15.19-8.61-7.89-3.54
EPS (Diluted)
-8.25-15.19-8.61-7.89-3.54
Free Cash Flow
-41.16-55.21-23.84-33.59-0.81
Free Cash Flow Per Share
-8.25-11.88-5.72-8.14-0.22
Gross Margin
57.02%52.28%77.21%81.41%-
Operating Margin
-215.71%-553.11%-418.91%-823.88%-
Profit Margin
-212.61%-534.69%-391.94%-817.16%-
Free Cash Flow Margin
-212.64%-418.22%-260.32%-842.60%-
EBITDA
-31.08-67.58-31.27-25.49-5.61
D&A For EBITDA
10.685.447.097.366.6
EBIT
-41.75-73.02-38.36-32.84-12.22
Source: S&P Capital IQ. Standard template. Financial Sources.